Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Report: Leighton Holdings internal emails discuss huge Iraq bribes

Internal emails leaked from Australia’s Leighton Holdings warn that a $24 million “facilitation payment” linked to a 2010 Iraq contract would “attract attention” from auditors.

Other emails talk about plans by senior employees to make payments to “friends” in the ­Middle East and to inflate and backdate contracts to win work in Iraq, the Financial Review reported Monday.… Continue Reading

SFO launches criminal probe of GSK

GlaxoSmith Kline PLC is under investigation by the UK Serious Fraud Office for possible criminal violations, the pharma said Tuesday.

In a two-sentence statement, UK-based GSK said it had been informed by the SFO of a formal criminal investigation into GSK’s commercial practices.… Continue Reading

Chinese police charge former GSK China chief Mark Reilly

Chinese police Wednesday charged the British former boss of GlaxoSmithKline’s China unit and two other company executives with corruption for bribing health officials and doctors.

A Ministry of Public Security official said in Beijing that Mark Reilly (pictured) and two Chinese executives, Zhang Guowei and Zhao Hongyan, offered bribes to hospital personnel and doctors to boost GSK’s sales.… Continue Reading

GSK confirms Jordan, Lebanon bribe probes

GlaxoSmithKline said it is investigating allegations of bribery in Jordan and Lebanon first reported by the media.

The UK-based pharma giant said in a statement Wednesday the probes are ongoing.

GSK said it has a “zero tolerance” for illegal behavior.… Continue Reading

GSK probes Iraq sales

British pharma GlaxoSmithKline said it is investigating allegations the company hired government-employed doctors and pharmacists in Iraq as paid sales reps for its products.

“We are investigating allegations of improper conduct in our Iraq business.… Continue Reading

Feds continue Halliburton Angola, Iraq investigations

Here’s the latest FCPA disclosure from oil field services firm Halliburton Company from its Form 10-K filed with the SEC on February 7:

_________

We are conducting internal investigations of certain areas of our operations in Angola and Iraq, focusing on compliance with certain company policies, including our Code of Business Conduct (COBC), and the FCPA and other applicable laws.… Continue Reading